相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mammalian Target of Rapamycin: Its Role in Early Neural Development and in Adult and Aged Brain Function
Carla Garza-Lombo et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas
Penelope Korkolopoulou et al.
HISTOPATHOLOGY (2012)
Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer
Nuria Juanpere et al.
HUMAN PATHOLOGY (2012)
Hypoxia-inducible factor and mammalian target of rapamycin pathway markers in urothelial carcinoma of the bladder: possible therapeutic implications
Satish K. Tickoo et al.
BJU INTERNATIONAL (2011)
The mTOR pathway affects proliferation and chemosensitivity of urothelial carcinoma cells and is upregulated in a subset of human bladder cancers
Igor Makhlin et al.
BJU INTERNATIONAL (2011)
Activation of the PI3K/Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder
Chih-Hao Sun et al.
HISTOPATHOLOGY (2011)
A Systematic Study of Gene Mutations in Urothelial Carcinoma; Inactivating Mutations in TSC2 and PIK3R1
Gottfrid Sjodahl et al.
PLOS ONE (2011)
Role of the mTOR Pathway in the Progression and Recurrence of Bladder Cancer: An Immunohistochemical Tissue Microarray Study
Se Jun Park et al.
KOREAN JOURNAL OF UROLOGY (2011)
Mammalian Target of Rapamycin (mTOR) Regulates Cellular Proliferation and Tumor Growth in Urothelial Carcinoma
Donna E. Hansel et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Expression Status and Prognostic Significance of Mammalian Target of Rapamycin Pathway Members in Urothelial Carcinoma of Urinary Bladder After Cystectomy
Luciana Schultz et al.
CANCER (2010)
4E-BP1 Is a Key Effector of the Oncogenic Activation of the AKT and ERK Signaling Pathways that Integrates Their Function in Tumors
Qing-Bai She et al.
CANCER CELL (2010)
The Phosphoinositide 3-Kinase Regulatory Subunit p85α Can Exert Tumor Suppressor Properties through Negative Regulation of Growth Factor Signaling
Cullen M. Taniguchi et al.
CANCER RESEARCH (2010)
Modulation of 4E-BP1 Function as a Critical Determinant of Enzastaurin-Induced Apoptosis
Chad A. Dumstorf et al.
MOLECULAR CANCER THERAPEUTICS (2010)
AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K
J. M. Askham et al.
ONCOGENE (2010)
Molecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progression
David J. McConkey et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
Activation of the mammalian target of rapamycin signalling pathway in prostate cancer and its association with patient clinicopathological characteristics
Bo Dai et al.
BJU INTERNATIONAL (2009)
Inhibition of mammalian target of rapamycin as a therapeutic strategy in the management of bladder cancer
Jose J. Mansure et al.
CANCER BIOLOGY & THERAPY (2009)
AKT1 E17 K pleckstrin homology domain mutation in urothelial carcinoma
Dorit E. Zilberman et al.
CANCER GENETICS AND CYTOGENETICS (2009)
Intravesical Delivery of Rapamycin Suppresses Tumorigenesis in a Mouse Model of Progressive Bladder Cancer
Catherine M. Seager et al.
CANCER PREVENTION RESEARCH (2009)
Inactivation of p53 and Pten promotes invasive bladder cancer
Anna M. Puzio-Kuter et al.
GENES & DEVELOPMENT (2009)
Mutant fibroblast growth factor receptor 3 induces intracellular signaling and cellular transformation in a cell type- and mutation-specific manner
E. di Martino et al.
ONCOGENE (2009)
Activation of extracellular regulated kinases (ERK1/2) predicts poor prognosis in urothelial bladder carcinoma and is not associated with B-Raf gene mutations
Maria Karlou et al.
PATHOLOGY (2009)
Rapamycin Inhibits In Vitro Growth and Release of Angiogenetic Factors in Human Bladder Cancer
Guido Fechner et al.
UROLOGY (2009)
Helical domain and kinase domain mutations in p110α of phosphatidylinositol 3-kinase induce gain of function by different mechanisms
Li Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer
D. C. Tomlinson et al.
JOURNAL OF PATHOLOGY (2007)
4E-Binding protein 1:: A key molecular Funnel factor in human cancer with clinical implications
Gemma Armengol et al.
CANCER RESEARCH (2007)
Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit
Nabil Miled et al.
SCIENCE (2007)
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
P. J. Roberts et al.
ONCOGENE (2007)
4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis
Federico Rojo et al.
CLINICAL CANCER RESEARCH (2007)
AKT activation in human glioblastomas enhances proliferation via TSC2 and S6 kinase signaling
Markus J. Riemenschneider et al.
CANCER RESEARCH (2006)
Ras, PI(3)K and mTOR signalling controls tumour cell growth
Reuben J. Shaw et al.
NATURE (2006)
A nuclear transport signal in mammalian target of rapamycin is critical for its cytoplasmic signaling to S6 kinase 1
RA Bachmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis
M Cully et al.
NATURE REVIEWS CANCER (2006)
Growing roles for the mTOR pathway
DD Sarbassov et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
Phosphorylation of mammalian target of rapamycin (mTOR) at ser-2448 is mediated by p70S6 kinase
GG Chiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
S6K1-/-/S6K2-/- mice exhibit perinatal lethality and rapamycin-sensitive 5′-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway
M Pende et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
The phosphatidylinositol-3 kinase pathway regulates bladder cancer cell invasion
X Wu et al.
BJU INTERNATIONAL (2004)
Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells
S Avdulov et al.
CANCER CELL (2004)
Translational control and metastatic progression: Enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs
JR Graff et al.
CLINICAL & EXPERIMENTAL METASTASIS (2003)
分享论文
